• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing

FXI and Alibaba Show the Chinese Recovery Has Reached an Inflection Point

I tend to doubt that a U.S. investor is going to exert much influence over a Chinese firm.
By BRUCE KAMICH
Jan 17, 2023 | 01:12 PM EST
Stocks quotes in this article: BABA, FXI

I returned to my desk Tuesday morning and did my usual "reading in" of news stories. I read that meme-stock "promoter" Ryan Cohen has built a stake in Chinese e-commerce giant Alibaba (BABA) and is reportedly ready to push for share buybacks. I don't want to delve that much into shares of BABA but rather look again at the (FXI) , the large-cap Chinese stock ETF.

In my December 30 review of FXI and BABA, I wrote that "Various pundits have been on FinTV voicing their opinions on what may lie ahead for China. In reality these are probably all sound guesses but I prefer to pay more attention to the price trends in the markets and these suggest more contraction in the months ahead." Let's check the charts again.

In this daily bar chart of FXI, below, I see a negative-looking picture. Let me explain. Prices have made three small "waves" higher from early November. The news flow has been bullish with media reports of fund buying, reopening economic strength and the ending of Covid restrictions.

Today I am reading about an American investor supposedly taking a big stake in BABA. Being more interested in the price action than the story I see the FXI is trading lower. Prices made a new high for the move up Monday and is likely to close below Monday's low Tuesday for a "close below the low of the high day" reversal signal. While trading volume looks like it has been more active since late October, it also looks like it has diminished during the past three months.

The daily On-Balance-Volume (OBV) line has moved up from early November but is now stalled at its early December zenith. The 12-day price momentum indicator shows lower highs from the middle of November telling me that the pace of the advance has slowed and this is a bearish divergence when compared to the price action making higher highs. Bearish divergences can foreshadow price declines at times. 

 
In this weekly Japanese candlestick chart of FXI, below, I can see that prices have pushed up into the halfway point of an overhead resistance zone from earlier this year in the $30-$35 area. Prices are above the bottoming 40-week moving average line.
 
The weekly OBV line is up from a mid-October low but it has not broken above its 2022 highs. The slow stochastic indicator (an overbought/oversold indicator) is in overbought territory suggesting that a correction could unfold in the days ahead.
 
 
In this daily Point and Figure chart of FXI, below, I can see that prices reached an upside price target in the $32 area.
 
 
In this weekly Point and Figure chart of FXI, below, I can see an upside price target in the $37 area but I also see potential overhead chart resistance.
 
In this daily Point and Figure chart of BABA, below, I see that prices have reached and exceeded an upside price target in the $99 area.
 
 
Bottom line strategy: BABA is just slightly over 10% of the FXI but the charts and indicators of the FXI are suggesting weakness ahead. I am a technical analyst but I tend to doubt that a U.S. investor is going to exert much influence over a Chinese firm.
 
I still look for the FXI and the Chinese economy to weaken. Avoid the long side of FXI and BABA.
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Emerging Markets | ETFs | Investing | Markets | Stocks | Technical Analysis | Trading | E-Commerce | China

More from Investing

Market's Frothy With a Side of FOMO

James "Rev Shark" DePorre
Jun 2, 2023 4:41 PM EDT

The small caps and the Dow finally host the party on Wall Street. But will this broadening action continue?

KLA Corp. Should Keep KLAC'ing Away

Bruce Kamich
Jun 2, 2023 2:30 PM EDT

Here's where the charts show this chipmaker heading.

This Is Still My 'Preferred' Style of Investing

Jim Collins
Jun 2, 2023 2:00 PM EDT

Let's look at some whopping returns for VLYPO and two others to dive into.

Is This 'Museum' Finally Unlocking Its Doors for Value Investors?

Jonathan Heller
Jun 2, 2023 12:50 PM EDT

A fascinating and frustrating company over the years, is showing positive signs in 2023.

Boosted by Quarterly Beat and AI's Breakout, Broadcom's Booming

Stephen Guilfoyle
Jun 2, 2023 11:56 AM EDT

Performance is excellent, free cash flow is robust, guidance is solid and sales are growing. Here's my one nitpick and how to play the stock.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 01:51 PM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Adjusting Your Trading Approach to Shifting Market...
  • 06:54 PM EDT CHRIS VERSACE

    AAP Podcast: A Tongue -- and a Market -- Twister: 'Get a Debt Deal Done'

    Listen in as the Action Alerts PLUS Podcast tackle...
  • 12:07 PM EDT STEPHEN GUILFOYLE

    Selling Some of This Surging AI-Related Stock

    This isn't the only name in the Stocks Under $10 p...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login